Novel β-phenylacrylic acid derivatives exert anti-cancer activity by inducing Src-mediated apoptosis in wild-type KRAS colon cancer

Cell Death & Disease
Su Jin KimEunok Im

Abstract

Many stress conditions including chemotherapy treatment is known to activate Src and under certain condition Src can induce the apoptotic signal via c-Jun N-terminal kinase (JNK) activation. Here we report that the newly synthesized β-phenylacrylic acid derivatives, MHY791 and MHY1036 (MHYs), bind to epidermal growth factor receptor (EGFR) tyrosine kinase domains and function as EGFR inhibitors, having anti-cancer activities selectively in wild-type KRAS colon cancer. Mechanistically, MHYs-induced Src/JNK activation which enhanced their pro-apoptotic effects and therefore inhibition of Src by the chemical inhibitor PP2 or Src siRNA abolished the response. In addition, MHYs generated reactive oxygen species and increased ER stress, and pretreatment with antioxidant-inhibited MHY-induced ER stress, Src activation, and apoptosis. Furthermore, the irreversible EGFR inhibitor PD168393 also activated Src while the reversible EGFR inhibitor gefitinib showed the opposite effect, indicating that MHYs are the irreversible EGFR inhibitor. Collectively, Src can play a key role in apoptosis induced by the novel EGFR inhibitor MHYs, suggesting that activation of Src might prove effective in treating EGFR/wild-type KRAS colon cancer.

References

Jan 1, 1993·The Journal of Clinical Investigation·M S TalamontiG E Gallick
Apr 15, 2000·The Journal of Biological Chemistry·M YoshizumiB C Berk
Nov 30, 2000·Molecular and Cellular Biology·B L WebbG S Martin
Jul 30, 2003·Cancer Metastasis Reviews·Justin M Summy, Gary E Gallick
Apr 13, 2004·Oncogene·Xavier SaelensPeter Vandenabeele
May 4, 2004·Oncogene·Ana CuadradoAlberto Muñoz
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jul 9, 2004·British Journal of Cancer·B F El-Rayes, P M LoRusso
Aug 3, 2004·Science·Douglas R Green, Guido Kroemer
Mar 11, 2006·Apoptosis : an International Journal on Programmed Cell Death·M LauricellaG Tesoriere
Sep 20, 2008·Virchows Archiv : an International Journal of Pathology·J H J M van KriekenA Ensari
Oct 22, 2008·Oncogene·D N Dhanasekaran, E P Reddy
Oct 24, 2008·The New England Journal of Medicine·Christos S KarapetisJohn R Zalcberg
Feb 18, 2010·Cancer Research·Alexander J MullerGeorge C Prendergast
Mar 16, 2011·Pathology Research International·Alyssa M Krasinskas
May 24, 2011·European Journal of Medicinal Chemistry·Gopal L KhatikVipin A Nair
Jul 23, 2011·Cell Death and Differentiation·H KatoM Kitamura
Jan 14, 2012·Expert Opinion on Therapeutic Targets·Parthasarathy SeshacharyuluSurinder K Batra
Sep 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R Dziadziuszko, J Jassem
Apr 2, 2013·Archives of Toxicology·Krishnendu SinhaParames C Sil
Aug 21, 2013·Cancer Chemotherapy and Pharmacology·Guanzhong ZhangShunchang Jiao
Sep 18, 2013·Oncogenesis·D AhmedR A Lothe
Nov 14, 2013·Current Clinical Pharmacology·Sanjay GoelLidija Klampfer
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Apr 15, 2015·Biochemical and Biophysical Research Communications·Xiu-Li ChengXue Gao
Apr 29, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marwan G Fakih
Jul 13, 2017·Oxidative Medicine and Cellular Longevity·Hanna-Riikka TeppoPeeter Karihtala

❮ Previous
Next ❯

Methods Mentioned

BETA
fluorescence-activated cell sorting
FACS
xenograft
xenografts
transfection
electrophoresis
immunoprecipitation

Software Mentioned

ABION
UCSF Chimera
FV10i
GraphPad Prism
GraphPad
AutoDock Vina
Chemdraw
MGL Tools
PyMol
fluoview

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis